首页 | 本学科首页   官方微博 | 高级检索  
检索        

Endoglin(CD105)在肿瘤新生血管靶向诊断及治疗中的应用
引用本文:杨华,邹利光.Endoglin(CD105)在肿瘤新生血管靶向诊断及治疗中的应用[J].临床肿瘤学杂志,2011,16(12):1130-1133.
作者姓名:杨华  邹利光
作者单位:400037 重庆 第三军医大学新桥医院放射科
基金项目:国家自然科学基金资助项目(810711197)
摘    要:Endoglin(CD105)是最可靠的内皮细胞增殖标志物,在肿瘤新生血管中过表达。基于Endoglin的靶向显像可以了解恶性肿瘤的血管生成情况,并为新生血管靶向治疗提供依据。在生物治疗方面,单克隆抗体在恶性肿瘤治疗中的地位越来越重要,因而基于抗Endoglin抗体的肿瘤靶向治疗在近年来受到广泛关注。本文将对基于Endoglin的靶向诊断及治疗作一简要综述。

关 键 词:肿瘤  血管生成  Endoglin/CD105  靶向显像  靶向治疗
收稿时间:2011-01-26
修稿时间:2011-03-23

The application of endoglin(CD105) in targeted diagnosis and treatment of malignant tumors
YANG Hua , ZOU Li-guang.The application of endoglin(CD105) in targeted diagnosis and treatment of malignant tumors[J].Chinese Clinical Oncology,2011,16(12):1130-1133.
Authors:YANG Hua  ZOU Li-guang
Institution:YANG Hua,ZOU Li-guang. Department of Radiology,Xinqiao Hospital,Third Military Medical University,Chongqing 400037,China
Abstract:Endoglin(CD105) is the most reliable marker of endothelial cell proliferation over-expressed in the tumor angiogenesis.Targeting imaging based on endoglin could evulate the angiogenesis of malignant tumors,and provide basis for targeted therapy of neovascular.In the field of biological treatment,monoclonal antibodies are becoming increasingly important in the treatment of human malignant tumor,therefore,anti-endoglin based tumor targeted therapy received extensive attention in recent years.In this paper,we ...
Keywords:Tumor  Angiogenesis  Endoglin/CD105  Targeted imaging  Targeted treatment  
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《临床肿瘤学杂志》浏览原始摘要信息
点击此处可从《临床肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号